4.7 Article

YBX1 mediates translation of oncogenic transcripts to control cell competition in AML

期刊

LEUKEMIA
卷 36, 期 2, 页码 426-437

出版社

SPRINGERNATURE
DOI: 10.1038/s41375-021-01393-0

关键词

-

资金

  1. German Research Council (DFG) [HE6233/4-2, HE6233/9-1, 97850925/SFB854, ME-1365/7-2, ME-1365/9-2]
  2. Thuringian Ministry for Research [RegenerAging -FSU-I-03/14]
  3. German Research Foundation (DFG) [PE 3217/1-1]
  4. Mark Foundation for Cancer Research
  5. Max Planck Society
  6. German Research Foundation (DFG/Gottfried Wilhelm Leibniz Prize)
  7. NIH [CA176745, CA206963, CA204639, CA066996]

向作者/读者索取更多资源

The study reveals the essential role of YBX1 in AML, with its inactivation reducing the competitive advantage of malignant cells, inhibiting leukemia cell proliferation, and playing a key role in oncogenic protein expression. This provides a new perspective for the treatment of AML.
Persistence of malignant clones is a major determinant of adverse outcome in patients with hematologic malignancies. Despite the fact that the majority of patients with acute myeloid leukemia (AML) achieve complete remission after chemotherapy, a large proportion of them relapse as a result of residual malignant cells. These persistent clones have a competitive advantage and can re-establish disease. Therefore, targeting strategies that specifically diminish cell competition of malignant cells while leaving normal cells unaffected are clearly warranted. Recently, our group identified YBX1 as a mediator of disease persistence in JAK2-mutated myeloproliferative neoplasms. The role of YBX1 in AML, however, remained so far elusive. Here, inactivation of YBX1 confirms its role as an essential driver of leukemia development and maintenance. We identify its ability to amplify the translation of oncogenic transcripts, including MYC, by recruitment to polysomal chains. Genetic inactivation of YBX1 disrupts this regulatory circuit and displaces oncogenic drivers from polysomes, with subsequent depletion of protein levels. As a consequence, leukemia cells show reduced proliferation and are out-competed in vitro and in vivo, while normal cells remain largely unaffected. Collectively, these data establish YBX1 as a specific dependency and therapeutic target in AML that is essential for oncogenic protein expression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据